Proton Therapy With Concurrent Chemotherapy for Thoracic Esophageal Cancer: Toxicity, Disease Control, and Survival Outcomes

PURPOSE: When treating esophageal cancer with radiation therapy, it is critical to limit the dose to surrounding structures, such as the lung and/or heart, as much as possible. Proton radiation therapy allows a reduced radiation dose to both the heart and lungs, potentially reducing the risk of card...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutenberg, Michael S., Hoppe, Bradford S., Starr, Jason S., Awad, Ziad, Thomas, Mathew, Morris, Christopher G., Johnson, Perry, Henderson, Randal H., Jones, Jeremy C., Gharia, Bharatsinh, Bowers, Steven, Wolfsen, Herbert C., Krishnan, Sunil, Ko, Stephen J., Babiker, Hani M., Nichols, Romaine C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Particle Therapy Co-operative Group 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875824/
https://www.ncbi.nlm.nih.gov/pubmed/36721483
http://dx.doi.org/10.14338/IJPT-22-00021.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875824/
https://www.ncbi.nlm.nih.gov/pubmed/36721483
http://dx.doi.org/10.14338/IJPT-22-00021.1

Ejemplares similares